ABSTRACT
INTRODUCTION
subfertility problems, subfertility being defined as absence of conception after at least 12 months of male factor can be identified. 1, 2 As disturbed spermatogenesis is the leading cause of male subfertility, assessment of the quality of spermatogenesis is the cornerstone in the evaluation and treatment of subfertile men. The Sertoli cell is the supporting cell of spermatogenesis and is important for its endocrine and paracrine control. 3 The aims of this review are: (1) to present current knowledge concerning Sertoli cell structure and function, with emphasis on new markers of spermatogenesis, and (2) to apply this knowledge within the clinical setting.
SERTOLI CELL: STRUCTURE AND FUNCTION
The parenchyma of the testes is divided by thin septula into conical lobules which consist of the seminiferous tubules and intertubular tissue. The seminiferous tubules are coiled loops whose two ends open into the spaces of the rete testis. The fluid secreted by the seminiferous tubules is collected in the rete testis and delivered to the ductal system of the epididymis. 4 The seminiferous tubule consists of the germinal epithelium and the peritubular tissue (lamina propria). The germinal epithelium consists of cells that include different developmental stages of germ cells, namely spermatogonia, primary and secondary spermatocytes and spermatids. These are located within invaginations of Sertoli cells.
Originally described by Enrico Sertoli in 1865, the somatic Sertoli cell performs a crucial "nursing" function in connection with spermatogenesis. Functions attributed to Sertoli cells are: (1) supportive and trophic functions for the cells of the seminiferous epithelium, (2) transport of mature spermatids towards the lumen of seminiferous tubules, (3) secretion of substances with endocrine or paracrine action for spermatogenesis control and (5) interaction with intertubular endocrine Leydig cells. 4 Sertoli cells are connected to each other by specialized zones of tight junctions of cellular membranes separating the germinal epithelium into a basal and an adluminal compartment. These tight junctions form the blood-testis barrier of the testis. During spermatogenesis, the germ cells pass this barrier entering the adluminal compartment where they find protection from diffusion of extraneous substances. 4 Thus, the blood-testis barrier does not separate the blood from testicular tissue but rather constitutes a delicate boundary between diploid and haploid germ cells. A well-functioning Sertoli cell provides the developing germ cells with appropriate mitogens, differentiation factors and sources of energy as well as protecting them from harmful agents and from the host's own immune system. 5 Sertoli cells produce: -ferrin, ceruloplasmin, plasminogen activator (PA), (2) growth factors, e.g. transforming growth factors anti-Müllerian hormone (AMH).
The first appearance of fetal Sertoli cells in the primitive gonad defines the initial stage in the development of the embryonic testis. These cells express the Sry gene, thereby determining the male sex of the gonad. As the exclusive source of AMH, Sertoli cells are also responsible for inhibiting the development of internal female genitalia. These cells together with another type of somatic testicular cell, the peritubular cell, are required for formation of the testis cords. The immature Sertoli cell differs extensively from the mature cell with respect to both morphology and biochemical activity. 5 As puberty approaches, the Sertoli cells become elongated and tight junctions are established between them. They begin to produce seminiferous fluid, which results in the transformation of the testis cords into seminiferous tubules possessing a lumen. The differentiated mature Sertoli cell alters its pattern of protein expression, starting to produce, e.g. transferrin and the inflammatory cytokine constantly, but this proliferative activity declines as puberty progresses and after tight junctions have been formed Sertoli cells are considered to no longer exhibit proliferative capacity. 5 Follicle Stimulating Hormone (FSH) is the major endocrine regulator of Sertoli cell function. The Sertoli cell is the only cell type in the testis that expresses receptors for this hormone which is necessary for adequate Sertoli cell proliferation. Spermatogenesis is dependent on the presence of an adequate intratesticular level of testosterone. Sertoli cells express the Androgen Receptor (AR), but germ cells do not, indicating that androgenic effects on the seminiferous epithelium are mediated via the Sertoli cell. AR is required for adequate functioning of the blood-testis barrier, as well as for meiosis and the post-meiotic development of germ cells, and its level of expression on Sertoli cells increases throughout the process of maturation. 5 The intertubular space of the human testis contains the microvasculature, endocrine Leydig cells, nerve fibres and connective tissue cells. 4 Leydig cells secrete hormones, mainly testosterone, into the vessels. The microvasculature of the intertubular space is divided into inter-Leydig cell capillaries of the arterial side, intramural capillaries in the peritubular wall of the Inhibin is a glycoprotein hormone of gonadal origin which was first identified by its ability to negatively regulate FSH. Inhibin consists of two disulphide-linked -molecular forms are found in circulation, biological activity resides only in the dimeric forms, inhibin A produced in the human male, where inhibin A is undetectable. 6 The Sertoli cell is considered the preis high during early postnatal life and then gradually declines to a still detectable plateau-level until the beginning of puberty when it again increases. 5 During puberty, the regulatory mechanism of inhibin controlled by substances produced by the germ cells. the first pubertal stages, when the last wave of Sertoli cell proliferation occurs, and a positive correlation 7 At Tanner -centrations correlate negatively, suggesting that the negative feedback regulation loop is fully established at this stage of development. At puberty, when Sertoli cell proliferation ceases and spermatogenesis starts, be considered to be an index of Sertoli cell number and integrity. Once full spermatogenesis is ongoing, the status of germ cell proliferation and development and depend only secondarily on FSH. In adult life, "amount" of spermatogenesis, as shown by the direct 7 AMH was named for its effect of causing regression of the Müllerian ducts, the anlagen of the uterus, fallopian tubes and upper vagina. 8 AMH is a homodimeric disulfide-linked glycoprotein with a molecular weight of 140 kD. Sertoli cells produce high levels of AMH from the time of fetal testicular differentiation up to puberty, at which time AMH expression decreases. Three factors regulate AMH expression by Sertoli cells: testosterone, FSH and spermatocytes entering prophase of the first meiotic division. Testosterone is the most important; in its absence or in the event of androgen insensitivity due to mutation of the androgen receptor, serum AMH concentrations remain high and even increase at puberty. FSH has a stimulating effect upon AMH expression by Sertoli cells, which is visible only in the absence of androgens. Maturation of germ cells also has an effect upon the expression of AMH by Sertoli cells; Sertoli cells in tubules in which germ cells have initiated meiosis cease to produce AMH earlier than those in which neighboring germ cells are still immature. AMH is secreted bidirectionally by Sertoli cells: apically into the seminiferous tubules and basally toward the interstitium and the circulation. Serum concentrations of AMH are maintained at a high level until puberty, when they decrease dramatically, remaining very low during adulthood. 9, 10 After puberty, AMH is secreted preferentially by the apical pole of the Sertoli cell, resulting in higher concentrations of AMH in the seminal plasma than in serum. 11 The
THE ROLE OF INHIBIN B AND AMH BASAL CONCENTRATIONS
to be significantly lower in men with testicular dysfunction compared with controls, as well as positively correlated with classical markers of spermatogenesis, such as sperm concentration, total sperm count and testicular volume.
3,12-14 Serum AMH concentrations have been found to be significantly lower 15, 16 or equal [17] [18] [19] in subfertile men compared with controls. Similarly, seminal AMH concentrations have been found to be significantly lower 11, [20] [21] [22] [23] or equal 15 in subfertile men compared with fertile controls. In order to further -fertility we designed a prospective control-matched study with the aim of determining serum inhibin causes of subfertility. 24 We prospectively studied 82 -cal, hormonal, sperm, imaging, testicular cytology and genetic results, an etiological classification of the 82 subfertile men was accomplished. We found significantly lower in subfertile men compared to control men. Moreover, there were significant differgroups of subfertile men, following a "progressive" pattern, with increasing concentrations as we moved from more severe (e.g. idiopathic non-obstructive azoospermia) to less severe testicular damage (e.g. varicocele). On the other hand, AMH concentrations were similar among men with different causes of subfertility, following an "all-or-nothing" pattern. This finding may suggest that AMH is more sensitive than results in a drastic decrease in AMH production. In seem to constitute additional diagnostic parameters in subfertile men and may be especially useful in cases of equivocal increases in serum FSH concentrations -ous epithelium.
THE ROLE OF INHIBIN B AND AMH STIMULATED CONCENTRATIONS
Several studies that evaluated serum concentrations fertile and subfertile men. 13, 17, [24] [25] Very few studies concentrations after administration of FSH. [26] [27] [28] [29] We attempted to evaluate basal and stimulated serum inhibin azoospermia (NOA). 30 Our initial hypothesis was that AMH concentrations in fertile controls but not in men with NOA; thus, the stimulated concentrations would prove to be better than basal concentrations in the discrimination between fertile controls and men with NOA. Thirty-seven men with NOA and 17 fertile controls were recruited and studied. All subfertile and control men underwent the Exogenous FSH SErtoli Reserve Test (EFSERT): estimation of serum inhibin -ter administration of 300 international units (IU) of human recombinant FSH (hrFSH), intramuscularly.
concentrations 24 h and 48 h after administration of hrFSH were lower in men with NOA as compared to controls. Similar differences at all time points were observed for serum AMH concentrations. However, in both NOA and control men, no change of serum throughout the EFSERT. As demonstrated by this study 30 as well as a review of literature, [26] [27] [28] [29] a bolus dose of up to 300 IU of hrFSH is not sufficient to -tions within the following 48 h. As the stimulation it seems that much more prolonged administration (presumably multiple injections over a period of two to three weeks) is required in order to achieve a -theless, such an administration renders EFSERT an impractical diagnostic tool for the evaluation of men with NOA. The stimulatory effect of FSH on inhibin of AMH, by the normal testosterone concentrations in the group of men with NOA, as there is evidence that the suppressive effect of LH-driven testicular androgens outweighs the stimulatory effect of FSH on Sertoli cells. 29 In conclusion, stimulated serum by an EFSERT, do not contribute to the diagnostic evaluation of men with NOA as the same information can be acquired by the basal serum concentrations of these hormones. Therefore, given the present evidence, we cannot recommend the use of EFSERT in clinical practice.
THE ROLE OF INHIBIN B AND AMH IN PREDICTION OF SPERM RETRIEVAL
The introduction into clinical practice of assisted reproduction techniques such as intracytoplasmic sperm injection (ICSI) made fatherhood possible for men with NOA. The extraction of sperm from the testis through fine-needle aspiration (FNA) or open biopsy (testicular sperm extraction -TESE) can result in a favorable reproductive outcome. Nevertheless, all these procedures are invasive in nature with variable possibility of successful sperm extraction. As a consequence, a non-invasive test that could predict the presence of sperm in men with NOA would be of profound clinical importance. Until recently, FSH and testicular volume constituted the best options to make such a prediction. Therefore, we designed a and AMH as predictors of the recovery of sperm in testicular FNA performed in men with azoospermia and compare their predictive value with that of FSH and testicular volume. 31 We prospectively recruited and studied 51 subfertile men with azoospermia. We levels following a "progressive" pattern with declining concentrations as we moved from less severe (e.g. mild hypospermatogenesis) to more severe cytological diagnosis (e.g. Sertoli Cell-Only Syndrome). On the other hand, there was no significant correlation between cytological diagnosis and AMH (Figure 2) . Receiver operating characteristic (ROC) curves were constructed using testicular FNA as the reference method (presence or absence of sperm). The Area for AMH, 0.714 for FSH and 0.693 for testicular volume. In pairwise comparison of ROC curves, there was no statistically significant difference among AUCs. Therefore, none of the four parameters was superior to the others. No significantly better sperm retrieval predictions were obtained with combination of the study variables (Figure 3 ). In conclusion, this study 31 did not provide evidence that serum inhibin testicular volume as predictors of the presence of sperm in testicular FNA in men with azoospermia.
A series of studies that attempted to estimate the AMH as non-invasive markers of persistent spermatogenesis in men with NOA have reported contradictory results. Therefore, we attempted to estimate this predictive value through a systematic review of diagnostic accuracy studies published in the literature and a meta-analysis of the best evidence available. 32 Studies which provided data on the accuracy of serum or seminal AMH and/or serum or seminal -ence of spermatozoa in sperm retrieval techniques in men with azoospermia were considered potentially eligible. Studies were included in the meta-analysis only if TESE (reference standard) was performed in men with NOA. After combining data regarding men with NOA from nine studies (a total of 726 of the presence of spermatozoa in TESE (Figure 4 FSH as a predictor of sperm retrieval, we performed a comparative analysis of the two hormones, in eight studies, where data were available. FSH demonstrated a sensitivity of 0.71 and a specificity of 0.62 as compared with 0.65 and 0.85, respectively for performance of the two hormones (sROC-AUC 0.70 -ter in correct identification of men with NOA and no spermatogenesis (higher specificity), whereas FSH is better in correct identification of men with NOA and foci of spermatogenesis (higher sensitivity). Even in the case that all available parameters (testicular size, sperm retrieval, the majority of men, at least in our practice, will decide to undergo a TESE procedure in an attempt to perform ICSI using their own genetic material. For this reason, we have applied a Fagan nomogram in order to counsel these men according to the principles of evidence based medicine ( Figure  6 ). In the studies included in the present meta-analysis the pre-test probability of successful sperm retrieval the case of the later, an alternative option, such as donor sperm, could be available.
CONCLUSIONS
to constitute additional diagnostic parameters in male subfertility as they reflect Sertoli cell function. Stimudo not add clinically relevant information regarding subfertile men compared to basal concentrations of -tions correlate with testicular histology/cytology but are not superior to FSH as predictors of the presence of sperm in TESE/FNA in men with azoospermia.
